Terumo Cardiovascular Reports the US FDA’s Approval of CDI OneView Monitoring System
Shots:
- The US FDA has granted 510(k) clearance to the company’s CDI OneView Monitoring System, enabling visualization of various measures at the time of cardiopulmonary bypass surgery to improve perfusion safety and patient outcomes
- The system is designed to evaluate ~22 parameters such as measured flow (Q), cardiac index (CI), regional cerebral oxygen saturation (rSO2), oxygen extraction ratio (O2ER), Area Under the DO2 Curve (AUC), and measured arterial oxygen saturation (SaO2)
- The system provides configurable and flexible parameter viewing to meet clinical needs while generating critical information for clinicians
Ref: Terumo | Image: Terumo
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
